The authors developed a small molecule targeting the circadian regulator BMAL1, enabling dose-dependent modulation of gene expression for circadian-controlled genes and downregulation of inflammatory pathways in macrophages.
- Hua Pu
- Laura C. Bailey
- Fraydoon Rastinejad
